Lyell Immunopharma

(NASDAQ) LYEL

Current Price$13.68

Market Cap$315.01M

Since IPO (2021)-96%

5 YearN/A

1 Year+39%

1 Month-30%

Lyell Immunopharma Financials at a Glance

Market Cap

$315.01M

Revenue (TTM)

$31.00K

Net Income (TTM)

-$246.41M

EPS (TTM)

-$12.74

P/E Ratio

-1.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$13.68

Volume

25,275.762

Open

$13.78

Price

$13.68

Volume

25,275.762

Open

$13.78

Previous Close

$13.50

Daily Range

$13.27 - $13.96

52-Week Range

$8.46 - $45.00

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$13.68

Volume

25,275.762

Open

$13.78

Previous Close

$13.50

Daily Range

$13.27 - $13.96

52-Week Range

$8.46 - $45.00

Estimated Earnings Date

Aug 12, 2026

LYEL News

Doctor with senior man_GettyImages-1147479334

Why Shares of Lyell Immunopharma Jumped This Week

James HalleyJun 16, 2023

LYEL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lyell Immunopharma

Industry

Biotechnology

Sector

Health Care

Employees

161

CEO

Lynn Seely, MD

Website

www.lyell.com

Headquarters

South San Francisco, CA 94080, US

LYEL Financials

Key Financial Metrics (TTM)

Gross Margin

-74%

Operating Margin

-6189%

Net Income Margin

-7949%

Return on Equity

-81%

Return on Capital

-61%

Return on Assets

-70%

Earnings Yield

-94.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$315.01M

Shares Outstanding

23.33M

Volume

25.28K

Avg. Volume

92.41K

Financials (TTM)

Gross Profit

-$11.50M

Operating Income

-$203.77M

EBITDA

-$262.91M

Operating Cash Flow

-$150.02M

Capital Expenditure

-$780.00K

Free Cash Flow

-$150.80M

Cash & ST Invst.

$247.22M

Total Debt

$50.99M

Lyell Immunopharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$2.00K

-71.4%

Gross Profit

-$2.33M

-33385.7%

Gross Margin

-1165.00%

N/A

Market Cap

$315.01M

N/A

Market Cap/Employee

$1.05M

N/A

Employees

300

N/A

Net Income

-$24.15M

+53.7%

EBITDA

-$21.82M

+55.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$254.02M

-15.7%

Total Debt

$48.85M

-14.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$39.49M

-19.2%

Short Term Debt

$9.36M

+13.7%

Return on Assets

-70.28%

N/A

Return on Invested Capital

-61.17%

N/A

Free Cash Flow

-$38.60M

+29.8%

Operating Cash Flow

-$38.51M

+29.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$15.48+1.57%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$6.86+2.47%

LRMRLarimar Therapeutics, Inc.

LRMRLarimar Therapeutics, Inc.$3.53+1.61%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$8.15+1.12%

EDITEditas Medicine, Inc.

EDITEditas Medicine, Inc.$2.58+3.00%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.37+2.38%

ALLOAllogene Therapeutics, Inc.

ALLOAllogene Therapeutics, Inc.$2.01+5.97%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.52+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.75+0.01%

CUPRCuprina (Cayman)

CUPRCuprina (Cayman)$10.33+1.60%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.27-0.09%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$177.08+0.10%

NOKNokia

NOKNokia$14.66-0.01%

NVDANvidia

NVDANvidia$212.20+0.03%

Questions About LYEL

What is the current price of Lyell Immunopharma?

Lyell Immunopharma is trading at $13.66 per share.

What is the 52-week range for Lyell Immunopharma?

Over the past 52 weeks, Lyell Immunopharma has traded between $8.46 and $45.00.

How much debt does Lyell Immunopharma have?

As of the most recent reporting period, Lyell Immunopharma reported total debt of $48.85M.

How much cash does Lyell Immunopharma have on hand?

Lyell Immunopharma reported $90.77M in cash and cash equivalents in its most recent financial results.

What is Lyell Immunopharma’s dividend yield?

Lyell Immunopharma does not currently have a dividend yield.

Lyell Immunopharma

Lyell Immunopharma Financials at a Glance

LYEL News

Why Shares of Lyell Immunopharma Jumped This Week

LYEL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lyell Immunopharma

LYEL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lyell Immunopharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LYEL

What is the current price of Lyell Immunopharma?

What is the 52-week range for Lyell Immunopharma?

How much debt does Lyell Immunopharma have?

How much cash does Lyell Immunopharma have on hand?

What is Lyell Immunopharma’s dividend yield?

Premium Investing Services